Insider Trading disclosures for Alnylam Pharmaceuticals Inc

The latest disclosure was made by Amy W. Schulman in Alnylam Pharmaceuticals Inc where a trade of 2,750 Common Stock done at an average price of $131.2 was reported to US exchanges on March 13, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Amy W. Schulman	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 131.21 per share.	13 Mar 2025	2,750	11,186 (0%)	0%	131.2	360,828	Common Stock
Amy W. Schulman	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Mar 2025	2,750	0	-		-	Stock Option (right to buy)
Yvonne L Greenstreet	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 247.35 per share.	03 Mar 2025	23	98,639 (0%)	0%	247.3	5,689	Common Stock
Yvonne L Greenstreet	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 246.18 per share.	03 Mar 2025	238	98,662 (0%)	0%	246.2	58,591	Common Stock
Yvonne L Greenstreet	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 245.26 per share.	03 Mar 2025	580	98,900 (0%)	0%	245.3	142,251	Common Stock
Yvonne L Greenstreet	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 244.41 per share.	03 Mar 2025	791	99,480 (0%)	0%	244.4	193,328	Common Stock
Yvonne L Greenstreet	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 243.36 per share.	03 Mar 2025	1,173	100,271 (0%)	0%	243.4	285,461	Common Stock
Yvonne L Greenstreet	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 242.37 per share.	03 Mar 2025	1,068	101,444 (0%)	0%	242.4	258,851	Common Stock
Yvonne L Greenstreet	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	17,965	102,512 (0%)	0%		0	Common Stock
Yvonne L Greenstreet	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	36,293	36,293	-		-	Stock Option (right to buy)
Yvonne L Greenstreet	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 248.25 per share.	03 Mar 2025	4	98,635 (0%)	0%	248.3	993	Common Stock
Jeffrey V. Poulton	EVP, Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 243.36 per share.	03 Mar 2025	382	48,283 (0%)	0%	243.4	92,964	Common Stock
Jeffrey V. Poulton	EVP, Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 245.26 per share.	03 Mar 2025	189	47,836 (0%)	0%	245.3	46,354	Common Stock
Jeffrey V. Poulton	EVP, Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 246.18 per share.	03 Mar 2025	77	47,759 (0%)	0%	246.2	18,956	Common Stock
Jeffrey V. Poulton	EVP, Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	15,117	49,015 (0%)	0%		0	Common Stock
Jeffrey V. Poulton	EVP, Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 247.29 per share.	03 Mar 2025	7	47,752 (0%)	0%	247.3	1,731	Common Stock
Jeffrey V. Poulton	EVP, Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 248.00 per share.	03 Mar 2025	1	47,751 (0%)	0%	248	248	Common Stock
Jeffrey V. Poulton	EVP, Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	9,800	9,800	-		-	Stock Option (right to buy)
Jeffrey V. Poulton	EVP, Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 242.37 per share.	03 Mar 2025	350	48,665 (0%)	0%	242.4	84,830	Common Stock
Jeffrey V. Poulton	EVP, Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 244.41 per share.	03 Mar 2025	258	48,025 (0%)	0%	244.4	63,058	Common Stock
Pushkal P. Garg	CMO & EVP Dev & Med Affairs	Sale of securities on an exchange or to another person at price $ 244.41 per share.	03 Mar 2025	158	26,493 (0%)	0%	244.4	38,617	Common Stock
Pushkal P. Garg	CMO & EVP Dev & Med Affairs	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	7,819	7,819	-		-	Stock Option (right to buy)
Pushkal P. Garg	CMO & EVP Dev & Med Affairs	Sale of securities on an exchange or to another person at price $ 242.70 per share.	03 Mar 2025	120	24,542 (0%)	0%	242.7	29,124	Common Stock
Pushkal P. Garg	CMO & EVP Dev & Med Affairs	Sale of securities on an exchange or to another person at price $ 241.60 per share.	03 Mar 2025	198	24,662 (0%)	0%	241.6	47,837	Common Stock
Pushkal P. Garg	CMO & EVP Dev & Med Affairs	Sale of securities on an exchange or to another person at price $ 240.92 per share.	03 Mar 2025	343	24,860 (0%)	0%	240.9	82,636	Common Stock
Pushkal P. Garg	CMO & EVP Dev & Med Affairs	Sale of securities on an exchange or to another person at price $ 239.25 per share.	03 Mar 2025	147	25,203 (0%)	0%	239.3	35,170	Common Stock
Pushkal P. Garg	CMO & EVP Dev & Med Affairs	Sale of securities on an exchange or to another person at price $ 245.53 per share.	03 Mar 2025	117	25,350 (0%)	0%	245.5	28,727	Common Stock
Pushkal P. Garg	CMO & EVP Dev & Med Affairs	Sale of securities on an exchange or to another person at price $ 244.43 per share.	03 Mar 2025	273	25,467 (0%)	0%	244.4	66,729	Common Stock
Pushkal P. Garg	CMO & EVP Dev & Med Affairs	Sale of securities on an exchange or to another person at price $ 243.13 per share.	03 Mar 2025	583	25,740 (0%)	0%	243.1	141,745	Common Stock
Pushkal P. Garg	CMO & EVP Dev & Med Affairs	Sale of securities on an exchange or to another person at price $ 248.00 per share.	03 Mar 2025	1	26,323 (0%)	0%	248	248	Common Stock
Pushkal P. Garg	CMO & EVP Dev & Med Affairs	Sale of securities on an exchange or to another person at price $ 247.40 per share.	03 Mar 2025	5	26,324 (0%)	0%	247.4	1,237	Common Stock
Pushkal P. Garg	CMO & EVP Dev & Med Affairs	Sale of securities on an exchange or to another person at price $ 246.19 per share.	03 Mar 2025	48	26,329 (0%)	0%	246.2	11,817	Common Stock
Pushkal P. Garg	CMO & EVP Dev & Med Affairs	Sale of securities on an exchange or to another person at price $ 245.26 per share.	03 Mar 2025	116	26,377 (0%)	0%	245.3	28,450	Common Stock
Pushkal P. Garg	CMO & EVP Dev & Med Affairs	Sale of securities on an exchange or to another person at price $ 243.36 per share.	03 Mar 2025	235	26,651 (0%)	0%	243.4	57,190	Common Stock
Pushkal P. Garg	CMO & EVP Dev & Med Affairs	Sale of securities on an exchange or to another person at price $ 242.37 per share.	03 Mar 2025	213	26,886 (0%)	0%	242.4	51,625	Common Stock
Pushkal P. Garg	CMO & EVP Dev & Med Affairs	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	14,137	27,099 (0%)	0%		0	Common Stock
Tolga Tanguler	EVP, Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	7,819	7,819	-		-	Stock Option (right to buy)
Tolga Tanguler	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 247.33 per share.	03 Mar 2025	3	28,011 (0%)	0%	247.3	742	Common Stock
Tolga Tanguler	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 246.17 per share.	03 Mar 2025	29	28,014 (0%)	0%	246.2	7,139	Common Stock
Tolga Tanguler	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 245.26 per share.	03 Mar 2025	70	28,043 (0%)	0%	245.3	17,168	Common Stock
Tolga Tanguler	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 244.41 per share.	03 Mar 2025	96	28,113 (0%)	0%	244.4	23,463	Common Stock
Tolga Tanguler	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 243.36 per share.	03 Mar 2025	142	28,209 (0%)	0%	243.4	34,557	Common Stock
Tolga Tanguler	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 242.37 per share.	03 Mar 2025	131	28,351 (0%)	0%	242.4	31,750	Common Stock
Tolga Tanguler	EVP, Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	14,137	28,482 (0%)	0%		0	Common Stock
Kevin Joseph Fitzgerald	CSO & EVP, Head of Research	Sale of securities on an exchange or to another person at price $ 245.30 per share.	03 Mar 2025	219	14,345 (0%)	0%	245.3	53,721	Common Stock
Kevin Joseph Fitzgerald	CSO & EVP, Head of Research	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	7,819	7,819	-		-	Stock Option (right to buy)
Kevin Joseph Fitzgerald	CSO & EVP, Head of Research	Sale of securities on an exchange or to another person at price $ 242.93 per share.	03 Mar 2025	71	13,501 (0%)	0%	242.9	17,248	Common Stock
Kevin Joseph Fitzgerald	CSO & EVP, Head of Research	Sale of securities on an exchange or to another person at price $ 241.68 per share.	03 Mar 2025	324	13,572 (0%)	0%	241.7	78,304	Common Stock
Kevin Joseph Fitzgerald	CSO & EVP, Head of Research	Sale of securities on an exchange or to another person at price $ 240.95 per share.	03 Mar 2025	328	13,896 (0%)	0%	241.0	79,032	Common Stock
Kevin Joseph Fitzgerald	CSO & EVP, Head of Research	Sale of securities on an exchange or to another person at price $ 239.24 per share.	03 Mar 2025	121	14,224 (0%)	0%	239.2	28,948	Common Stock

Showing 1 to 50 of 500 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

78.27% Gain from 52W Low

Insider Trading disclosures for Alnylam Pharmaceuticals Inc

The latest disclosure was made by Amy W. Schulman in Alnylam Pharmaceuticals Inc where a trade of 2,750 Common Stock done at an average price of $131.2 was reported to US exchanges on March 13, 2025.

Screeners based on Insider Trading and SAST parameters